Haider, A., Haider, K., Doros, G., Traish, A., & Saad, F. (2019). SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting. J Endocr Soc.
Chicago Style citaatHaider, Ahmad, Karim Haider, Gheorghe Doros, Abdulmaged Traish, en Farid Saad. "SAT-533 Men With Hypogonadism and Osteoporosis Benefit From Long-Term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU) Regardless of Co-Medication With Bisphosphonates: 10-Year Data From a Controlled Registry Study in a Urological Setting." J Endocr Soc 2019.
MLA citatieHaider, Ahmad, et al. "SAT-533 Men With Hypogonadism and Osteoporosis Benefit From Long-Term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU) Regardless of Co-Medication With Bisphosphonates: 10-Year Data From a Controlled Registry Study in a Urological Setting." J Endocr Soc 2019.